These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Eosinophilia-myalgia syndrome (L-tryptophan-associated neuromyopathy). Turi GK; Solitare GB; James N; Dicker R Neurology; 1990 Nov; 40(11):1793-6. PubMed ID: 2234439 [TBL] [Abstract][Full Text] [Related]
7. The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. Dicker RM; James N; Cunha BA Ann Intern Med; 1990 Jun; 112(12):957-8. PubMed ID: 2339856 [TBL] [Abstract][Full Text] [Related]
8. Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients. Verity MA; Bulpitt KJ; Paulus HE Hum Pathol; 1991 Jan; 22(1):3-11. PubMed ID: 1985074 [TBL] [Abstract][Full Text] [Related]
9. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751 [TBL] [Abstract][Full Text] [Related]
17. Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group. Philen RM; Eidson M; Kilbourne EM; Sewell CM; Voorhees R Arch Intern Med; 1991 Mar; 151(3):533-7. PubMed ID: 2001136 [TBL] [Abstract][Full Text] [Related]